{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T09:52:42Z","timestamp":1649065962430},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T00:00:00Z","timestamp":1582588800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T00:00:00Z","timestamp":1582588800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s00120-020-01150-8","type":"journal-article","created":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T09:03:36Z","timestamp":1582621416000},"page":"480-483","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nephroureterektomie beim Urothelkarzinom des oberen Harntraktes"],"prefix":"10.1007","volume":"59","author":[{"given":"Annabel","family":"Spek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,25]]},"reference":[{"issue":"1","key":"1150_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel\u00a0RL, Miller\u00a0KD, Jemal\u00a0A (2018) Cancer statistics, 2018. CA Cancer J Clin 68(1):7\u201330","journal-title":"CA Cancer J. Clin."},{"issue":"10","key":"1150_CR2","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1111\/j.1464-410X.2009.08838.x","volume":"104","author":"P Colin","year":"2009","unstructured":"Colin\u00a0P, Koenig\u00a0P, Ouzzane\u00a0A, Berthon\u00a0N, Villers\u00a0A, Biserte\u00a0J et\u00a0al (2009) Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract. BJU Int 104(10):1436\u20131440","journal-title":"BJU Int"},{"key":"1150_CR3","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1002\/cncr.22970","volume":"110(8","author":"G Novara","year":"2007","unstructured":"Novara\u00a0G, De Marco\u00a0V, Gottardo\u00a0F, Dalpiaz\u00a0O, Bouygues\u00a0V, Galfano\u00a0A et al (2007) Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers. Cancer 110(8:1715\u20131722","journal-title":"Cancer"},{"issue":"1","key":"1150_CR4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.eururo.2017.07.036","volume":"73","author":"M Roupret","year":"2018","unstructured":"Roupret\u00a0M, Babjuk\u00a0M, Comperat\u00a0E, Zigeuner\u00a0R, Sylvester\u00a0RJ, Burger\u00a0M et\u00a0al (2018) European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update. Eur Urol 73(1):111\u2013122","journal-title":"Eur Urol"},{"issue":"6","key":"1150_CR5","doi-asserted-by":"publisher","first-page":"e1055","DOI":"10.1016\/j.clgc.2017.07.009","volume":"15","author":"CH Lee","year":"2017","unstructured":"Lee\u00a0CH, Ku\u00a0JY, Jeong\u00a0CW, Ku\u00a0JH, Kwak\u00a0C, Kim\u00a0HH et\u00a0al (2017) Predictors for Intravesical Recurrence Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A National Multicenter Analysis. Clin Genitourin Cancer 15(6):e1055\u2013e61","journal-title":"Clin Genitourin Cancer"},{"issue":"3","key":"1150_CR6","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00345-016-1826-2","volume":"35","author":"A Mbeutcha","year":"2017","unstructured":"Mbeutcha\u00a0A, Roupret\u00a0M, Kamat\u00a0AM, Karakiewicz\u00a0PI, Lawrentschuk\u00a0N, Novara\u00a0G et\u00a0al (2017) Prognostic factors and predictive tools for upper tract urothelial carcinoma: a\u00a0systematic review. World J Urol 35(3):337\u2013353","journal-title":"World J Urol"},{"issue":"1","key":"1150_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1159\/000338644","volume":"89","author":"D Hirano","year":"2012","unstructured":"Hirano\u00a0D, Okada\u00a0Y, Nagane\u00a0Y, Satoh\u00a0K, Mochida\u00a0J, Yamanaka\u00a0Y et\u00a0al (2012) Intravesical Recurrence after Surgical Management of Urothelial Carcinoma of the Upper Urinary Tract. Urol Int 89(1):71\u201377","journal-title":"Urol Int"},{"issue":"9","key":"1150_CR8","first-page":"1041","volume":"16","author":"TW Flaig","year":"2018","unstructured":"Flaig\u00a0TW, Spiess\u00a0PE, Agarwal\u00a0N, Bangs\u00a0R, Boorjian\u00a0SA, Buyyounouski\u00a0MK et\u00a0al (2018) NCCN Guidelines Insights: Bladder Cancer, Version 5.2018. JNCCN 16(9):1041\u20131053","journal-title":"JNCCN"},{"issue":"5","key":"1150_CR9","first-page":"1229","volume":"20","author":"P Wu","year":"2015","unstructured":"Wu\u00a0P, Zhu\u00a0G, Wei\u00a0D, Liu\u00a0S, Walsh\u00a0K, Li\u00a0D et al (2015) Prophylactic intravesical chemotherapy decreases bladder tumor recurrence after nephroureterectomy for primary upper tract urothelial carcinoma: A systematic review and meta-analysis. Journal of BUON : official journal of the Balkan Union of. Oncology 20(5):1229\u20131238","journal-title":"Oncology"},{"issue":"4","key":"1150_CR10","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1179\/1973947815Y.0000000034","volume":"27","author":"H Yuan","year":"2015","unstructured":"Yuan\u00a0H, Mao\u00a0X, Bai\u00a0Y, Li\u00a0H, Liu\u00a0L, Pu\u00a0C et al (2015) The effect of intravesical chemotherapy in the prevention of intravesical recurrence after nephroureterectomy for upper tract urothelial carcinoma: a\u00a0meta-analysis. J\u00a0Chemother 27(4):195\u2013200","journal-title":"J Chemother"},{"issue":"3","key":"1150_CR11","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1159\/000350508","volume":"91","author":"D Fang","year":"2013","unstructured":"Fang\u00a0D, Li\u00a0XS, Xiong\u00a0GY, Yao\u00a0L, He\u00a0ZS, Zhou\u00a0LQ (2013) Prophylactic intravesical chemotherapy to prevent bladder tumors after nephroureterectomy for primary upper urinary tract urothelial carcinomas: a\u00a0systematic review and meta-analysis. Urol Int 91(3):291\u2013296","journal-title":"Urol Int"},{"issue":"12","key":"1150_CR12","first-page":"4734","volume":"7","author":"X Deng","year":"2014","unstructured":"Deng\u00a0X, Yang\u00a0X, Cheng\u00a0Y, Liu\u00a0X, Wu\u00a0B, Wang\u00a0Z et\u00a0al (2014) Prognostic value and efficacy valuation of postoperative intravesical instillation in primary urothelial carcinomas of upper urinary tract. Int J Clin Exp Med 7(12):4734\u20134746","journal-title":"Int J Clin Exp Med"},{"issue":"3","key":"1150_CR13","doi-asserted-by":"publisher","first-page":"113.e1","DOI":"10.1016\/j.urolonc.2016.10.016","volume":"35","author":"DD Lu","year":"2017","unstructured":"Lu\u00a0DD, Boorjian\u00a0SA, Raman\u00a0JD (2017) Intravesical chemotherapy use after radical nephroureterectomy: A national survey of urologic oncologists. Urologic oncology 35(3):113.e1\u2013113.e7","journal-title":"Urologic oncology"},{"key":"1150_CR14","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1200\/JCO.2012.45.2128","volume":"31(11","author":"A Ito","year":"2013","unstructured":"Ito\u00a0A, Shintaku\u00a0I, Satoh\u00a0M, Ioritani\u00a0N, Aizawa\u00a0M, Tochigi\u00a0T et\u00a0al (2013) Prospective randomized phase II trial of a\u00a0single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group Trial. J\u00a0Clin Oncol 31(11:1422\u20131427","journal-title":"J Clin Oncol"},{"issue":"4","key":"1150_CR15","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.eururo.2011.05.064","volume":"60","author":"T O\u2019Brien","year":"2011","unstructured":"O\u2019Brien\u00a0T, Ray\u00a0E, Singh\u00a0R, Coker\u00a0B, Beard\u00a0R (2011) Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a\u00a0prospective, multicentre, randomised clinical trial of a\u00a0single postoperative intravesical dose of mitomycin C (the ODMIT\u2011C Trial). Eur Urol 60(4):703\u2013710","journal-title":"Eur Urol"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-020-01150-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-020-01150-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-020-01150-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T00:23:50Z","timestamp":1614126230000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-020-01150-8"}},"subtitle":["Wirksamkeit einer Einzeldosis der intravesikalen Chemotherapie"],"short-title":[],"issued":{"date-parts":[[2020,2,25]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["1150"],"URL":"https:\/\/doi.org\/10.1007\/s00120-020-01150-8","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,25]]},"assertion":[{"value":"25 February 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"A.\u00a0Spek gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}